UK approves world’s 1st gene therapy to treat sickle-cell, thalassemia
London, Nov 18 (IANS) The UK has approved the world's first gene therapy to treat blood disorders sickle-cell disease and thalassemia using the gene-editing tool CRISPR, which won its inventors the Nobel Prize in 2020.So far, a bone marrow…
Read More...
Read More...